Phase 3 trials
- India
DGCI nod for Sanofi-GSK’s phase 3 trial of Covid vax in India
Mumbai:The Drugs Controller General of India (DGCI) has granted approval to Sanofi and Glaxo Smith Kline (GSK) to conduct Phase-III clinical study, to assess the safety, efficacy and immunogenicity of their adjuvanted…
- Hyderabad
Covaxin’s Phase 3 trials results likely next month
Hyderabad: The results of third phase trials of India’s first indigenously developed COVID-19 vaccine Covaxin are expected to be released next month.Covaxin manufacturer Bharat Biotech said its service provider, IQVIA, has started…
